What does this research mean for the field?

AI-assisted analytical workflows significantly improve pharmaceutical analysis by reducing method development time and enhancing predictive accuracy, though widespread industrial implementation remains restricted by validation, bias, interpretability, and regulatory challenges. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To critically review recent advances in artificial intelligence and machine learning applications for pharmaceutical analysis, continuous manufacturing, and real-time quality control.

August 19, 2026Discover Artificial IntelligenceOpen Access

Artificial intelligence assisted pharmaceutical analysis for sustainable quality monitoring and continuous manufacturing applications

View Full Paper

Ask AI

Bookmark

Authors

AGAnnasaheb S. GaikwadB. J. Medical College & Sassoon Hospital SPSonali B. PawarHindu College of Pharmacy

Discussion

Member takes

Implication

Literature review demonstrates AI improves quality monitoring and efficiency in continuous pharmaceutical manufacturing, suggesting pathways toward sustainable drug production.

Key Points

To critically review recent advances in artificial intelligence and machine learning applications for pharmaceutical analysis, continuous manufacturing, and real-time quality control.
Conducted a structured literature search across PubMed, Scopus, Web of Science, ScienceDirect, SpringerLink, and Google Scholar databases covering 2020 through early 2026.
Evaluated studies integrating AI with Quality by Design (QbD) and Process Analytical Technology (PAT) across chromatography, impurity profiling, and stability prediction.
AI-assisted analytical workflows substantially accelerated method development timelines and improved predictive accuracy for stability and impurity assessments.
Integration of AI with QbD and PAT supported real-time continuous manufacturing monitoring while enhancing analytical sustainability.
Industrial adoption remains restricted by limited validation datasets, algorithmic bias, model interpretability challenges, and regulatory uncertainty.

Cite This Study

Gaikwad et al. (2026) studied this question.

synapsesocial.com/papers/6a85630603308d306e2d6072 https://doi.org/10.1007/s44163-026-01927-4

View Full Paper

Ask AI

Bookmark

Implication

Literature review demonstrates AI improves quality monitoring and efficiency in continuous pharmaceutical manufacturing, suggesting pathways toward sustainable drug production.

Artificial intelligence assisted pharmaceutical analysis for sustainable quality monitoring and continuous manufacturing applications

Discussion

Member takes

Implication

Key Points

Cite This Study

Artificial intelligence assisted pharmaceutical analysis for sustainable quality monitoring and continuous manufacturing applications

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider